# Transcript verification

Verdict **fail**, coverage **74/100**, **23 findings**.

## Findings by category

| Category | Findings |
| --- | --- |
| Distortion | 5 |
| Unsourced addition | 8 |
| Omission | 8 |
| Underexplained | 2 |

## Findings

### Distortion

#### Critical — The structured version universalises the two-stage model by stating that carcinogenesis requires both initiation and promotion. The lecturer presents this as a useful model and experimental paradigm, not an absolute requirement for every cancer, and repeatedly uses qualified language about possible mechanisms.

- **In the structured transcript:** Initiators vs Promoters: The Two-Stage Model — opening sentence
- **In the source:** Initiator/promoter discussion following the asbestos example

> “So we have mutagens and we have promoters.”; “Not all causes of cancer are potentially due to mutagens which are causing DNA damage, but also processes which provide the right microenvironment…”

**Suggested fix:** Qualify the statement as a two-stage model demonstrated in the mouse-skin experiment, rather than a universal requirement for all carcinogenesis.

#### Major — The lymphoma-belt rainfall threshold is converted to greater than 50 mm. The source says “greater than 50 mils” and does not support conversion to millimetres; the intended epidemiological threshold is likely a substantially different unit, so the structured number is high-risk.

- **In the structured transcript:** Burkitt Lymphoma and the Lymphoma Belt — defining criteria
- **In the source:** Burkitt lymphoma — description of the lymphoma belt

> “A minimum temperature of 60 degrees Fahrenheit, a yearly rainfall of greater than 50 mils, and regions 10 degrees to the north and south of the equator.”

**Suggested fix:** Do not convert the rainfall unit without verification; retain the source wording or mark the unit as unclear.

#### Major — Asbestos is labelled a “Pure Promoter” and the tentative interpretation is presented categorically. The lecturer says there is no evidence that fibres directly damage DNA and repeatedly frames the promoter model as current thinking rather than settled exclusivity.

- **In the structured transcript:** Asbestos as a Pure Promoter — heading and opening sentences
- **In the source:** Asbestos and chronic-inflammation discussion

> “There's no evidence that asbestos fibers cause DNA damage.”; “We think what happens here…”; “So we consider this to be promoter activity rather than initiator.”

**Suggested fix:** Preserve the evidential qualification and avoid the stronger term “pure promoter.”

#### Minor — The geographic section converts exploratory observations into stronger conclusions. It says gastric and liver cancers in East Asia are driven by diet and endemic infections, and that melanoma is high in Australia, whereas the lecturer poses these as questions or hypotheses rather than established conclusions in this dataset.

- **In the structured transcript:** Epidemiology and Geographic Variation — melanoma and gastric/liver bullets
- **In the source:** Epidemiology and geographic-incidence comparisons

> “Why are they high in Asia? What happens in Asia…? And we're going to think about different geographic variations of infections as well.”; “Melanoma, well, why wouldn't it be higher in Australia?”

**Suggested fix:** Preserve the hypothesis-generating language and distinguish observed incidence differences from proposed explanations.

#### Minor — The migrant study is strengthened to say breast-cancer rates rose “to match the host nation.” The source supports a shift toward more breast cancer and away from the Japanese pattern of stomach cancer but does not state that rates matched the US population.

- **In the structured transcript:** Epidemiology and Geographic Variation — migrant-study paragraph
- **In the source:** Post-WWII Japanese migrant example

> “When a lot of Japanese migrants moved to the US, instead of developing stomach cancer… they started to develop more breast cancer.”

**Suggested fix:** Describe the directional incidence shift without claiming complete convergence with host-nation rates.

### Unsourced addition

#### Major — The mutational-signatures section supplies exact lesion and substitution profiles for UV, ROS, PAHs, and alkylating agents. The transcript only says that these agents produce visibly different patterns and gives C-to-A changes as an illustrative sequencing context; it does not state the detailed signatures listed.

- **In the structured transcript:** High-Throughput Mutational Signatures — four-agent list
- **In the source:** the source carries no such passage

**Suggested fix:** Remove or explicitly identify the exact signature assignments as supplementary material not contained in the transcript.

#### Major — The Burkitt mechanism is expanded with unsupported specifics: Plasmodium falciparum, class-switch recombination, somatic hypermutation as the precise event at this step, and the canonical t(8;14). The source supports malaria, germinal-centre proliferation, simultaneous IG heavy-chain and MYC activity, and a translocation placing MYC by the heavy-chain enhancer, but not these added details.

- **In the structured transcript:** Burkitt Lymphoma and the Lymphoma Belt — distribution and Mechanism paragraphs
- **In the source:** the source carries no such passage

**Suggested fix:** Restrict the mechanism to the level supplied by the lecturer or label the added molecular specifics as external clarification.

#### Major — Multiple pathogen entries add species, histological subtype, or mechanism not given in the transcript: Schistosoma haematobium and bladder squamous carcinoma; Aspergillus flavus and hepatocellular carcinoma; direct HPV effects on p53 and pRb; and HTLV-1 viral transactivators. These may be external domain knowledge, but they have no explicit transcript basis.

- **In the structured transcript:** Infectious Pathogens in Carcinogenesis — pathogen bullet list
- **In the source:** the source carries no such passage

**Suggested fix:** Limit entries to the transcript's level of specificity or distinguish externally supplied details from transcript-derived content.

#### Major — The developmental-susceptibility section adds several mechanisms or outcomes absent from the source: O6-methylguanine as the NMU lesion, fixation into an expanding mammary stem-cell compartment, hormone-driven ductal branching, breast cancer as the specified atomic-bomb outcome, and terminal differentiation/reduction of progenitor cells as the parity mechanism.

- **In the structured transcript:** Developmental Timing and Tissue Susceptibility
- **In the source:** the source carries no such passage

**Suggested fix:** Retain the supported claims—AT-to-GC transitions, greater mammary-tumour susceptibility in pubertal female rats, greater cancer susceptibility among teenagers and girls after atomic-bomb exposure, and the observed association with younger first pregnancy—without supplying unreferenced mechanisms or outcomes.

#### Major — The Berenbaum account adds promoter reversibility, repeated promoter dosing, the specific production of papillomas and carcinomas, and a promoter-alone experimental arm. The transcript explicitly reports initiator alone and the importance of sequence, but does not provide all of these details.

- **In the structured transcript:** The Berenbaum Paradigm — experiment-result bullets
- **In the source:** the source carries no such passage

**Suggested fix:** Restrict the experimental findings to those described: DMBA alone did not produce skin cancer, DMBA followed by TPA did, and reversing the order did not.

#### Minor — The structured transcript names breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). The source only describes a lymphoma arising around implants and does not name its subtype.

- **In the structured transcript:** Environmental Mutagens — breast implants bullet
- **In the source:** the source carries no such passage

**Suggested fix:** Use the source's generic description or mark BIA-ALCL as external identification.

#### Minor — Chemical sections add nomenclature and source details not supplied by the transcript, including “aflatoxin B1,” stored grains, benzo[a]pyrene diol epoxide, industrial dyes as a source of beta-naphthylamine, and transitional/squamous bladder-cancer subtypes.

- **In the structured transcript:** Aflatoxin B1; PAHs and Benzo[a]pyrene; Aromatic Amines and Tissue Specificity
- **In the source:** the source carries no such passage

**Suggested fix:** Remove the unsupported specificity or distinguish it from transcript-derived content.

#### Minor — The Ames-test section identifies Salmonella typhimurium, minimal-histidine medium, defined biosynthesis mutations, and S9 homogenate. The transcript specifies only a histidine-dependent bacterial strain, plating after exposure, reversion to his-positive growth, and rat liver extract enriched in P450 enzymes.

- **In the structured transcript:** In Vitro Mutagenicity: The Ames Test
- **In the source:** the source carries no such passage

**Suggested fix:** Either stay at the transcript's level of detail or identify the organism and S9 terminology as supplementary technical clarification.

### Omission

#### Major — The lecture's concluding clinical and public-health framing—dose and potency, and the need to balance carcinogenic risk against benefit—is largely absent. This includes the examples of medical X-rays, tanning, herbicides, and the point that many exposures are too low-dose to produce the effects seen in toxicology studies.

- **In the structured transcript:** Methodologies for Determining Carcinogenicity and Summary
- **In the source:** Final toxicology discussion and lecture summary

> “Ultimately, it's all about the risks versus the benefits. We know that medical X-rays can cause DNA damage, but you need to know if you have a broken bone.”; “The amount of toxin we're exposed to may also play a role.”; “Working out the potency of carcinogens is even more challenging.”

**Suggested fix:** Represent dose, potency, exposure level, and benefit-versus-risk analysis as central limitations and conclusions of carcinogenicity assessment.

#### Major — The structured epidemiology section omits the lecturer's central warning that epidemiological associations are vulnerable to confounding and potentially misleading statistical presentation. It also loses the specific caveat that lung cancer occurs in non-smokers despite the strong smoking association.

- **In the structured transcript:** Epidemiology and Geographic Variation; Population Epidemiology and Biobanks
- **In the source:** Introduction to epidemiology and later carcinogenicity-methods discussion

> “There are lots of cool things you can do with statistics to make your epidemiological study look in whatever way you want. There's lots of caveats. There's lots of confounders.”; “But of course, you also get lung cancer in non-smokers, so it's not as clear cut.”

**Suggested fix:** Include confounding, interpretation bias, imperfect exposure/outcome specificity, and the distinction between association and proof.

#### Major — The structured account of NMU omits the dietary and two-factor oesophageal-cancer example: alkylating-agent exposure from fermented foods or salted fish combined with tissue damage and inflammation from extremely hot drinks.

- **In the structured transcript:** Developmental Timing and Tissue Susceptibility — before or within the NMU bullet
- **In the source:** Alkylating agents and oesophageal cancer, before the rat study

> “NMU… is prevalent in fermented foods.”; “This has been associated with eating fermented foods such as salted fish, but also with taking extremely hot drinks.”; “The mutagen… and these extremely hot drinks cause DNA damage and inflammation, which together increases the risk…”

**Suggested fix:** Include this example because it concretely links an initiator-like dietary mutagen with inflammatory promotion.

#### Major — The aflatoxin discussion loses the important HBV cofactor example. The lecturer notes that aflatoxin-exposed populations also have high HBV prevalence and proposes HBV-associated chronic inflammation as promotional activity.

- **In the structured transcript:** Aflatoxin B1 or Population Epidemiology and Biobanks
- **In the source:** Epidemiological examples in the carcinogenicity-methods section

> “That example of aflatoxin exposure with liver cancer. And actually, these people also have a high rate of HBV infection. So we think that may also be playing a role in this promotional activity, this chronic inflammation.”

**Suggested fix:** Represent aflatoxin and HBV as an example of interacting mutagenic and inflammatory/promotional exposures.

#### Minor — The quantitative microplastics example is compressed to “significant quantities,” losing the lecturer's memorable estimate of approximately one credit card's worth per day and the explicit statement that there is currently no evidence of mutagenicity.

- **In the structured transcript:** Environmental Mutagens — microplastics bullet
- **In the source:** Environmental exposures — microplastics

> “We consume about a credit card's worth of microplastics every day.”; “Could these be mutagenic? There's no evidence quite yet…”

**Suggested fix:** Retain the numerical analogy and the explicit no-current-evidence caveat.

#### Minor — The structured version loses the practical asbestos caveat that intact material is comparatively safe and that the hazard arises when it is damaged and fibres are released.

- **In the structured transcript:** Environmental Mutagens — asbestos bullet
- **In the source:** Initial environmental-exposure examples

> “Asbestos is pretty safe… as long as it's not broken and the fibers are released.”

**Suggested fix:** Retain the distinction between intact asbestos-containing material and released inhalable fibres.

#### Minor — The specific epidemiological example of smoking being associated with squamous cell carcinoma of the bronchus is omitted, despite the instruction to preserve specific cancer examples.

- **In the structured transcript:** Population Epidemiology and Biobanks or Environmental Mutagens
- **In the source:** Examples of exposure–cancer associations in the carcinogenicity-methods section

> “Smoking and squamous cell carcinoma of the bronchus.”

**Suggested fix:** Retain the named histological example alongside the general smoking–lung cancer association.

#### Minor — The structured account omits TCDD's association with birth defects, a distinct adverse-outcome example given alongside its indirect carcinogenic mechanism.

- **In the structured transcript:** 2,3,7,8-Tetrachlorodibenzodioxin (TCDD)
- **In the source:** TCDD and Agent Orange discussion

> “It has indirect effects on DNA and is also associated with lots of birth defects.”

**Suggested fix:** Retain the birth-defect association as an additional consequence of exposure.

### Underexplained

#### Major — HRT is reduced to evidence that some tumours rely on hormonal signalling. The structured version loses the lecturer's reasoning about variable-quality epidemiological evidence, later estimates suggesting a lower risk than initially believed, menopausal symptom burden, and individual clinical risk-benefit decisions.

- **In the structured transcript:** Environmental Mutagens — HRT bullet
- **In the source:** Environmental-exposure examples — hormone replacement therapy

> “A lot of this came from epidemiological studies, some of them weaker than others. And since it's been shown that perhaps the risk isn't quite as high as we think…”; “We also have to think medically about the risks, the balance.”

**Suggested fix:** Restore the evidential uncertainty and clinical risk-benefit framing rather than presenting HRT only as a hormone-dependence example.

#### Minor — The saccharin example is compressed to a generic warning about supra-physiological dosing. It loses the observed negative rat experiment despite very high intake, the lecturer's mention of reported cancer links, and the gallons-of-soft-drink analogy used to explain human dose extrapolation.

- **In the structured transcript:** In Vivo Animal Bioassays
- **In the source:** Limitations of rodent carcinogenicity studies

> “We were feeding rats tons and tons of saccharin in their food, but they didn't develop cancer.”; “I'd have to be drinking gallons of Coke every day… to see mutations in my DNA.”

**Suggested fix:** Retain the experimental outcome and dose analogy as the concrete illustration of extrapolation limits.

## Considered and not raised

The checker examined and cleared **5 passages**.

- *"“I'm Suzanne Turner… some of you have met me through the practical classes.”"* — Opening introduction. Lecturer identification and class-administration material were reviewed but treated as non-substantive; the structured version preserves most of it anyway.
- *"Daily Mail comments about smoking, Tai Chi, ginger and garlic, and cancer-research conspiracy theories."* — Public interpretation of the Tomassetti and Vogelstein papers. These were humorous public-understanding asides rather than evidence or mechanisms. Their substantive lesson—that “bad luck” must not be interpreted as making exposure irrelevant—is preserved.
- *"Burkitt treating children with methotrexate in his kitchen, publication as a single author, and formal naming in 1963."* — Historical account of Denis Burkitt. Reviewed as historical lecturer colour rather than necessary causal or methodological content. The discovery narrative relevant to EBV and geographic mapping is preserved.
- *"Repeated returns to cigarette smoke and the “roulette wheel of cancer.”"* — Throughout the environmental-carcinogenesis discussion. Repetition and rhetorical signposting were intentionally not treated as missing concepts; the underlying claims about tobacco acting through mutagens and inflammation remain represented.
- *"“Bye. [laughs]” and “[audience applauding]”"* — Incidental interruption and lecture ending. Non-content chatter and audience reaction were correctly excluded.
